Top Markets
Coin of the day
OptiNose, Inc. OptiNose, Inc.

OptiNose, Inc.

OPTN
Peringkat dalam Saham #9145
OptiNose, Inc. is a specialized pharmaceutical company primarily focused on... OptiNose, Inc. is a specialized pharmaceutical company primarily focused on innovating and bringing to market treatments for individuals under the care of ear, nose, throat, and allergy specialists throughout the United States. Its flagship product, XHANCE, utilizes the company's proprietary exhalation delivery system (EDS) to administer a topically-acting corticosteroid. This therapy is approved for treating chronic rhinosinusitis when accompanied by nasal polyps and is currently undergoing Phase IIIb clinical trials for broader chronic sinusitis treatment. The company also offers Onzetra Xsail, a powder-based EDS device, which is commercialized via a licensing agreement with Currax Pharmaceuticals LLC. Further expanding its pipeline, OptiNose is developing OPN-019, an investigational product that integrates a liquid EDS device with an antiseptic agent. Additionally, OptiNose has formed a partnership with Inexia Limited. This collaboration centers on the development, manufacturing, importation, and sale of products containing orexin receptor agonist or positive modulator molecules, intended for the treatment, diagnosis, or prevention of human conditions predominantly linked to orexin receptor activity. Established in 2000, OptiNose, Inc. operates from its corporate headquarters in Yardley, Pennsylvania.
Harga Saham
$9.60
Terakhir disinkronkan: 2025-05-21
Kapitalisasi Pasar
$1.08B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan OptiNose, Inc. (OPTN)

Kategori

Rasio P/E untuk OptiNose, Inc. (OPTN)
Rasio P/E per August 2026 TTM: -4.53
Menurut laporan keuangan dan harga saham terbaru dari OptiNose, Inc., rasio P/E saat ini (TTM) adalah -4.53. Pada akhir 2023, perusahaan memiliki rasio P/E sebesar -61.12.
Riwayat rasio P/E untuk OptiNose, Inc. dari 2015 hingga 2026
Rasio P/E di akhir setiap tahun
Tahun Rasio P/E Mengubah
2026 (TTM) -4.53 43.76%
2024 -3.15 -94.85%
2023 -61.12 2,778.17%
2022 -2.12 -87.45%
2021 -16.92 -44.50%
2020 -30.49 -42.65%
2019 -53.16 53.32%
2018 -34.67 -82.13%
2017 -194.05 -666.28%
2016 34.27 -112.74%
2015 -268.92 0.00%
Rasio P/E untuk perusahaan serupa atau pesaing
Bagaimana cara membaca P/E ratio?

Rasio Harga/Laba (P/E) mengukur hubungan antara harga saham perusahaan dan laba per sahamnya.
P/E yang rendah namun positif menunjukkan perusahaan dengan laba tinggi dibandingkan valuasinya saat ini dan mungkin dianggap undervalued. P/E negatif tinggi (mendekati 0) menunjukkan perusahaan yang mengalami kerugian besar.

Perusahaan dengan P/E di atas 30 atau negatif umumnya dianggap sebagai "saham pertumbuhan", artinya investor mengharapkan pertumbuhan atau keuntungan di masa depan.

Perusahaan dengan P/E positif di bawah 10 dianggap sebagai "saham bernilai", artinya perusahaan sudah sangat menguntungkan dan pertumbuhannya kemungkinan tidak besar.